Gabe Longoria joins 4basebio following a successful tenure as Chief Commercial Officer at Astrea Bioseparations Ltd. 4basebio ...

GEMMA Biotherapeutics —a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson—has named May Orfali, MD, ...

Biopharmaceutical company Mabwell has announced a significant milestone for its proprietary Nectin-4 targeted ADC (9MW2821).

Boehringer Ingelheim has licensed Synaffix B.V.’s ADC technology, significantly bolstering its ADC portfolio with the goal of ...

Samsung Biologics, a global contract development and manufacturing organization (CDMO), has extended its collaboration with ...

Peptone, a biotech company developing novel therapeutics targeting intrinsically disordered proteins (IDPs) to treat diseases ...

Alchemab Therapeutics, a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies ...

Bora Biologics, a division of CDMO Bora Pharmaceuticals, will support DotBio, a biopharmaceutical company specializing in ...

Under the agreement, UCB gains a non-exclusive license to leverage XtalFold for the discovery and engineering of biologics.

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...

The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in 4Q24, and Genenta expects to treat six ...

The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...